help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peri, A.
Right arrow Articles by Spada, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peri, A.
Right arrow Articles by Spada, A.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 5 2111-2117
Copyright © 2001 by The Endocrine Society


Original Studies

Expression of Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Responsive Element Binding Protein and Inducible-cAMP Early Repressor Genes in Growth Hormone-Secreting Pituitary Adenomas with or without Mutations of the Gs{alpha} Gene

Alessandro Peri, Barbara Conforti, Silvana Baglioni-Peri, Paola Luciani, Federica Cioppi, Lisa Buci, Sabrina Corbetta, Emilia Ballaré, Mario Serio and Anna Spada

Endocrine Unit (A.P., B.C., P.L., F.C., L.B., M.S.) and Medical Genetics Unit (S.B.-P.), Department of Clinical Physiopathology, University of Florence, 50139 Florence, Italy; and Institute of Endocrine Sciences, Ospedale Maggiore, University of Milan (S.C., E.B., A.S.), 20122 Milan, Italy

Address all correspondence and requests for reprints to: Alessandro Peri, M.D., Ph.D., Endocrine Unit, Department of Clinical Physiopathology, University of Florence, Viale Pieraccini, 6, 50139 Florence, Italy. E-mail: a.peri{at}dfc.unifi.it

In about 30–40% of GH-secreting adenomas, gain-of-function mutations of the Gs{alpha} gene, which convert this gene into an oncogene termed gsp, occur. Gs{alpha} mutations have been related to pituitary tumorigenesis. We focused on 2 nuclear transcription factors that are final targets of the cAMP-dependent pathway and are positively regulated by cAMP signaling, i.e. the cAMP-responsive element binding protein (CREB) and the inducible cAMP early repressor (ICER), that derives from alternative splicing of cAMP-responsive element modulator gene. We examined 21 GH-secreting adenomas, 8 with (gsp+) and 13 without (gsp-) a mutated Gs{alpha}. Analysis of CREB and ICER I/II messenger RNA revealed that the levels of both transcripts were higher in gsp+ than in gsp- tumors (CREB/glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mean optical density ± SE, 2.34 ± 0.36 in gsp+ vs. 0.99 ± 0.22 in gsp-, P = 0.003; ICER I/GAPDH, 0.53 ± 0.15 in gsp+ vs. 0.14 ± 0.07 in gsp-, P = 0.01; ICER II/GAPDH, 1.5 ± 0.21 in gsp+ vs. 0.83 ± 0.13 in gsp-, P = 0.01), although a few cases in both groups did not display this pattern of expression. Moreover, no positive correlation between the levels of CREB and ICER transcripts was observed, suggesting the possible presence of alterations in the mechanisms by which cAMP signaling directs the expression of CREB and/or ICER genes. Our results indicate a complex pattern of expression of nuclear transcription factors that mediate cAMP action in both gsp+ and gsp- tumors, suggesting that, beside Gs{alpha} gene mutations, different and partially unknown molecular events may contribute to the pathogenesis of these tumors.




This article has been cited by other articles:


Home page
EndocrinologyHome page
D. Romano, K. Magalon, M. Pertuit, R. Rasolonjanahary, A. Barlier, A. Enjalbert, and C. Gerard
Conditional Overexpression of the Wild-Type Gs{alpha} as the gsp Oncogene Initiates Chronic Extracellularly Regulated Kinase 1/2 Activation and Hormone Hypersecretion in Pituitary Cell Lines
Endocrinology, June 1, 2007; 148(6): 2973 - 2983.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Luciani, S. Gelmini, E. Ferrante, A. Lania, S. Benvenuti, S. Baglioni, G. Mantovani, I. Cellai, F. Ammannati, A. Spada, et al.
Expression of the Antiapoptotic Gene Seladin-1 and Octreotide-Induced Apoptosis in Growth Hormone-Secreting and Nonfunctioning Pituitary Adenomas
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6156 - 6161.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Lania, G. Mantovani, and A. Spada
Genetics of Pituitary Tumors: Focus on G-Protein Mutations
Experimental Biology and Medicine, October 1, 2003; 228(9): 1004 - 1017.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. Mead, T. R. Hughes, S. A. Irvine, N. N. Singh, and D. P. Ramji
Interferon-gamma Stimulates the Expression of the Inducible cAMP Early Repressor in Macrophages through the Activation of Casein Kinase 2. A POTENTIALLY NOVEL PATHWAY FOR INTERFERON-gamma -MEDIATED INHIBITION OF GENE TRANSCRIPTION
J. Biol. Chem., May 9, 2003; 278(20): 17741 - 17751.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Peri, P. Luciani, B. Conforti, S. Baglioni-Peri, F. Cioppi, C. Crescioli, P. Ferruzzi, S. Gelmini, G. Arnaldi, G. Nesi, et al.
Variable Expression of the Transcription Factors cAMP Response Element-Binding Protein and Inducible cAMP Early Repressor in the Normal Adrenal Cortex and in Adrenocortical Adenomas and Carcinomas
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5443 - 5449.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society